General
Preferred name
MOLINDONE
Synonyms
MOLINDONE HYDROCHLORIDE ()
Minolteparin sodium molindone ()
EN-1733A ()
(±)-Molindone ()
Moban ()
Molindonum ()
SPN-810M ()
Molindone (hydrochloride) ()
Molindone hcl ()
Molindona ()
Spn-810 ()
Molindon ()
P&D ID
PD009446
CAS
15622-65-8
7416-34-4
65973-37-7
Tags
available
drug
Approved by
FDA
First approval
1974
Drug indication
Schizophrenia
Psychosis
Drug Status
approved
withdrawn
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Molindone hydrochloride (EN-1733A) is a therapeutic antipsychotic, used in the treatment of schizophrenia, works by blocking the effects of dopamine in the brain, leading to diminished psychoses.
PRICE
29
DESCRIPTION
Marketed formulations may contain molindone hydrochloride (PubChem CID 9883259).
(GtoPdb)
PRICE
516
DESCRIPTION
Molindone ((??)-Molindone) is a therapeutic antipsychotic used to treat schizophrenia by blocking the action of dopamine in the brain. molindone is often used in combination with serotonin in a dose-dependent manner to increase errors and decrease response rates.
DESCRIPTION
D2 dopamine receptor antagonist; monoamine oxidase inhibitor
(LOPAC library)
DESCRIPTION
Molindone hydrochloride (EN-1733A) is an indole derivative effective in treating schizophrenia and other psychoses by blocking dopamine's effects in the brain.
(TargetMol Bioactive Compound Library)
DESCRIPTION
Molindone acts by antagonizing dopamine (D2) receptor sites in the reticular limbic systems in the brain, thus decreasing dopamine activity. Molindone is an indole derivative effective in schizophrenia and other psychoses and possibly useful in the treatment of the aggressive type of undersocialized conduct disorder.
(Enamine Bioactive Compounds)
DESCRIPTION
Molindone ((±)-Molindone) is a therapeutic antipsychotic used to treat schizophrenia by blocking the action of dopamine in the brain. molindone is often used in combination with serotonin in a dose-dependent manner to increase errors and decrease response rates.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
0
Organisms
2
Compound Sets
27
Axon Medchem Screening Library
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Enamine Bioactive Compounds
Enamine BioReference Compounds
Guide to Pharmacology
Ki Database
LOPAC library
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
NIH Clinical Collections (NCC)
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
The Spectrum Collection
Withdrawn 2.0
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
57
Molecular Weight
276.18
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
1
Rotatable Bonds
3
Ring Count
3
Aromatic Ring Count
1
cLogP
1.96
TPSA
45.33
Fraction CSP3
0.69
Chiral centers
1.0
Largest ring
6.0
QED
0.92
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Selectivity
D2
Target
5-HT
dopamine
mAChR
Dopamine Receptor
D2 antagonist
ATC
N05AE02
Pathway
GPCR/G protein
Neuroscience
Neuronal Signaling
Therapeutic Class
Antipsychotic Agents
Source data

